Wikidata

(Q40669413)

English

KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosis

scientific article published on 20 February 2003

In more languages

Statements

title
KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12595316
retrieved
22 September 2017
author name string
David M Lucas
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12595316
retrieved
22 September 2017
Andrew P Mone
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12595316
retrieved
22 September 2017
Joshua B Kitner
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12595316
retrieved
22 September 2017
Joseph J Drabick
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12595316
retrieved
22 September 2017
Michael R Grever
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
12595316
retrieved
22 September 2017
publication date
20 February 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
12595316
retrieved
22 September 2017
page(s)
4547-4550
1 reference
stated in
Europe PubMed Central
PubMed ID
12595316
retrieved
22 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40669413&oldid=1904419260"